Claims
- 1. A method for measuring carbon dioxide in a liquid sample, comprising the steps of:
- (1) reacting bicarbonate ion in said sample with phosphoenolpyruvate carboxylase and phosphoenolpyruvate;
- (2) reacting the resultant oxalacetic acid with malate dehydrogenase and NADH; and
- (3) measuring the decreased NADH, wherein said phosphoenolpyruvate carboxylase is derived from a species of acetic acid bacteria selected from the group consisting of Acetobacter pasteurianus, Acetobacter xylinum and Gluconobacter oxydans, and said reacting steps (1) and (2) are carried out in a solution containing 50-100 mM magnesium ions and having a pH of 7.5-9.0.
- 2. The method of claim 1, wherein said phosphoenolpyruvate carboxylase is derived from Acetobacter pasteurianus.
- 3. The method of claim 1, wherein said phosphoenolpyruvate carboxylase is derived from Acetobacter xylinum.
- 4. The method of claim 1, wherein said phosphoenolpyruvate carboxylase is derived from Gluconobacter oxydans.
- 5. The method of claim 1, wherein said solution is a buffer having a pH of 8.0-8.5.
- 6. The method of claim 1, wherein the step of measuring the decrease in NADH is accomplished by measuring absorbance of a reaction mixture.
- 7. The method of claim 1, wherein said liquid sample is a body fluid.
- 8. The method of claim 7, wherein said body fluid is blood serum or blood plasma.
- 9. A reagent for measuring carbon dioxide, comprising phosphoenolpyruvate, phosphoenolpyruvate carboxylase, malate dehydrogenase, NADH, a butter having a pH of 7.5-9.0 and 50-100 mM magnesium ions, wherein said phosphoenolpyruvate carboxylase is derived from a species of acetic acid bacteria selected from the group consisting of Acetobacter pasteurianus, Acetobacter xylinum and Gluconobacter oxydans.
- 10. The reagent of claim 9, wherein said phosphoenolpyruvate carboxylase is derived from Acetobacter pasteurianus.
- 11. The reagent of claim 9, wherein said phosphoenolpyruvate carboxylase is derived from Acetobacter xylinum.
- 12. The reagent of claim 9, wherein said phosphoenolpyruvate carboxylase is derived from Gluconobacter oxydans.
- 13. The reagent of claim 9, having a pH of 8.0-8.5.
- 14. The reagent of claim 9, comprising 10-50 mM weak alkaline buffer, 2-5 mM phosphoenolpyruvate, 50-100 mM magnesium ions, 0.3-1.5 mM NADH, 5-50 U/ml malate dehydrogenase and 0.5-10 U/ml phosphoenolpyruvate carboxylase derived from the acetic acid bacteria.
- 15. The reagent of claim 9, comprising 10-50 mM weak alkaline buffer, 2-5 mM phosphoenolpyruvate, 50-100 mM magnesium ions, 0.1-0.2 mM NADH, 5-50 U/ml malate dehydrogenase and 0.05-1 U/ml phosphoenolpyruvate carboxylase derived from the acetic acid bacteria.
Priority Claims (1)
Number |
Date |
Country |
Kind |
5-61987 |
Mar 1993 |
JPX |
|
Parent Case Info
The present application is a continuation-in-part of U.S. Ser. No. 08/210,559, filed Mar. 18, 1994 now U.S. Pat. No. 5,547,851.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
3963578 |
Aitken et al. |
Jun 1976 |
|
Non-Patent Literature Citations (1)
Entry |
Tietz, et al, 1986, Clinical Chemistry, W.B. Saunders Co., London, pp. 1188-1189, 1190. |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
210559 |
Mar 1994 |
|